United Laboratories International Holdings Ltd (HKSE:03933) Share Price

Company Profile

Business description
United Laboratories International Holdings Ltd is mainly engaged in the research and development, production and sales of pharmaceuticals. The company operates in three segments: Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. The majority of the company's sales are generated in China, followed by Europe, India and other countries.
Contact
No. 6 Fuk Wang Street
Yuen Long Industrial Estate
New Territories
Hong Kong
HKG
T: +852 26871033
http://www.tul.com.cn
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
17,400

Recommended

The magnitude of growth at Broadcom continues to astound us.

William Kerwin, CFA | 10 September 2025

The banking major needs to prevent key product offerings from falling further behind the competition.

Nathan Zaia | 10 September 2025

A great fiscal 2025 but investors are ahead of themselves.

Mark Taylor | 08 September 2025

Index	Last price	Change	% Change
All Ordinaries	9,095.20	28.80	0.32%
CAC 40	7,791.68	42.29	0.55%
DAX 40	23,773.44	54.99	0.23%
Dow JONES (US)	45,711.34	196.39	0.43%
FTSE 100	9,280.46	37.93	0.41%
HKSE	26,200.26	262.13	1.01%
NASDAQ	21,879.49	80.79	0.37%
Nikkei 225	43,837.67	378.38	0.87%
NZX 50 Index	13,276.24	22.51	0.17%
S&P 500	6,512.61	17.46	0.27%
S&P/ASX 200	8,830.40	40.00	0.46%
SSE Composite Index	3,812.22	4.93	0.13%